Gastrointestinal Cancers

Expert faculty review and share their insights and perspectives on key findings in gastrointestinal cancers presented at the 2020 ASCO Annual Meeting

Share

Program Content

Activities

  • Expert Analysis
    Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting
    Conference Coverage
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 07, 2020

    Expires: August 06, 2021

  • Downloadable Slideset
    Key Studies in Gastrointestinal Cancers from the 2020 ASCO Virtual Scientific Meeting
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 07, 2020

    Expires: August 06, 2021

Activities

DESTINY-CRC01
Phase II DESTINY-CRC01: Trastuzumab Deruxtecan in Patients With HER2-Expressing Metastatic Colorectal Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

PRODIGE 23
PRODIGE 23: Phase III Trial of Neoadjuvant mFOLFIRINOX Plus CRT vs Preoperative CRT in Locally Advanced Rectal Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2020

Expires: June 04, 2021

RTOG 1010
Phase III RTOG 1010: Addition of Trastuzumab to Trimodality Treatment in Resectable HER2-Positive Esophageal Adenocarcinoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2020

Expires: June 01, 2021

SWOG S1505
SWOG S1505: Phase II Study of Perioperative CT With mFOLFIRINOX vs Gemcitabine/nab-Paclitaxel in Resectable Pancreatic Ductal Adenocarcinoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

DESTINY-Gastric01
DESTINY-Gastric01: Trastuzumab Deruxtecan in Previously Treated, HER2+ Advanced Gastric or GEJ Adenocarcinoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

KEYNOTE-177
KEYNOTE-177: Phase III Trial of First-line Pembrolizumab vs Chemotherapy in MSI-H/dMMR Metastatic CRC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

Faculty

cover img faculity

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.